The Effects of the Mediterranean Diet on Health and Gut Microbiota
Overview
Affiliations
The Mediterranean Diet (MD) is plant-based and consists of multiple daily portions of vegetables, fruit, cereals, and olive oil. Although there are challenges with isolating the MD from the typical Mediterranean lifestyle and culture (including prolonged 'social' meals and siestas), much evidence supports the health benefits of the MD that include improved longevity, reduced metabolic risk of Diabetes Mellitus, obesity, and Metabolic Syndrome, reduced risk of malignancy and cardiovascular disease, and improved cognitive function. The MD is also associated with characteristic modifications to gut microbiota, mediated through its constituent parts (primarily dietary fibres, extra virgin olive oil, and polyunsaturated fatty acids [including ω-3]). These include enhanced growth of species that produce short-chain fatty acids (butyrate), such as and , enhanced growth of , , and species, and reduced growth of Firmicutes and species. Such changes in gut microbiota are known to be associated favourably with inflammatory and oxidative status, propensity for malignancy and overall metabolic health. A key challenge for the future is to explore the extent to which the health benefits of the MD are mediated by such changes to gut microbiota. The MD confers both health and environmental benefits. Adoption of the MD should perhaps be encouraged and facilitated more generally and not just restricted to populations from Mediterranean regions. However, there are key challenges to this approach that include limited perennial availability of the constituent parts of the MD in some non-Mediterranean regions, intolerability of a high-fibre diet for some people, and potential cultural disconnects that juxtapose some traditional (including Western) diets with the MD.
Francini E, Badillo Pazmay G, Fumarola S, Procopio A, Olivieri F, Marchegiani F Int J Mol Sci. 2025; 26(4).
PMID: 40004221 PMC: 11855466. DOI: 10.3390/ijms26041759.
Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management.
Barber T, Kabisch S, Pfeiffer A, Weickert M Metabolites. 2025; 15(2).
PMID: 39997710 PMC: 11857510. DOI: 10.3390/metabo15020085.
Redruello-Requejo M, Del Mar Blaya M, Gonzalez-Reguero D, Robas-Mora M, Arranz-Herrero J, Partearroyo T Nutrients. 2025; 17(3).
PMID: 39940246 PMC: 11820480. DOI: 10.3390/nu17030388.
Leaky Gut Syndrome: An Interplay Between Nutrients and Dysbiosis.
Marcari A, Paiva A, Simon C, Dos Santos M Curr Nutr Rep. 2025; 14(1):25.
PMID: 39890659 DOI: 10.1007/s13668-025-00614-7.
Yu J, Wu Y, Zhu Z, Lu H Nutr J. 2025; 24(1):17.
PMID: 39875854 PMC: 11773984. DOI: 10.1186/s12937-024-01060-x.